Inflammation  >>  Dexycu (dexamethasone intraocular injection)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dexycu (dexamethasone intraocular injection) / EyePoint Pharma, Ocumension Therap
NCT02006888: The Efficacy and Safety of IBI-10090 for the Treatment of Inflammation Associated With Cataract Surgery

Completed
3
394
US
IBI-10090, Dexycu, Placebo
ICON Bioscience Inc
Inflammation, Cataracts
10/14
10/14
NCT02547623: Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery

Completed
3
194
US
Dexamethasone, Dexycu, Prednisolone, standard of care
ICON Bioscience Inc
Cataract
08/16
08/16
NCT06429306: Study of Dexycu in Treating Intraocular Inflammation

Completed
3
285
RoW
Dexycu, Investigational product, Placebo
Ocumension Therapeutics (Shanghai) Co., Ltd
Inflammation, Cataract
11/23
04/24

Download Options